EP3142751
And-B7-H1 og and-CTLA-4 mótefni til að meðhöndla lungnakrabbamein sem ekki er smáfrumukrabbamein
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.5.2015EP published:
7.8.2019EP application number:
15722195.3
EP translation filed:
2.10.2019Grant published:
15.10.2019EPO information:
European Patent Register
Max expiry date:
11.5.2035Expiry date:
11.5.2026Next due date:
31.5.2026
Title:
ANTI-B7-H1 AND ANTI-CTLA-4 ANTIBODIES FOR TREATING NON-SMALL CELL LUNG CANCER
Timeline
Today
12.5.2015EP application
7.8.2019EP Publication
2.10.2019Translation submitted
15.10.2019Registration published
11.5.2026Expires
Owner
Name:
MedImmune LimitedAddress:
Milstein Building Granta Park, CambridgeCambridgeshire CB21 6GH, GB
Inventor
Name:
NARWAL, RajeshAddress:
GaithersburgMaryland, US
Name:
ROBBINS, PaulAddress:
GaithersburgMaryland, US
Name:
KARAKUNNEL, JoysonAddress:
GaithersburgMaryland, US
Name:
DAR, Mohammed M.Address:
GaithersburgMaryland, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461992658 PDate:
13.5.2014Country:
US
Number:
201562105992 PDate:
21.1.2015Country:
US
Number:
201562114336 PDate:
10.2.2015Country:
US
Classification
Categories:
A61P 35/00, A61K 39/395, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 4.5.2020
Expires: 11.5.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.4.2021
Expires: 11.5.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.4.2022
Expires: 11.5.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.4.2023
Expires: 11.5.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.4.2024
Expires: 11.5.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.5.2025
Expires: 11.5.2026
Payer: Árnason Faktor ehf.